http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-028534-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3bfb54197654df1cdd08467e147dad10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4523 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427 |
| filingDate | 2011-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e872b8f0e58556733692d237ffad384 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_568d3d5f20957aad17aaac9220c1ec71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_791be30a584611a88297f6593c60bd4c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1481896c72333d7140f5cf8d3badcea |
| publicationDate | 2017-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-028534-B1 |
| titleOfInvention | A METHOD FOR THE RESTORATION OF MEMORY, DAMAGED AS A RESULT OF PATHOLOGY, ADVERSE EFFECTS OR TIME |
| abstract | The invention relates to a method for recovering a memory lost due to pathology, adverse effects or time. The method includes the introduction of an effective amount of alkyl derivatives of amides of the general formula I, in which n and m can take the values 0, 1, 2 and 3; a sign (#) indicates the presence of a chiral center; R is an optionally substituted C-Saryl or 5-6-membered hetaryl containing 1-2 heteroatoms selected from nitrogen and sulfur, possibly condensed with a benzene ring, and the substituents are selected from C-C1-6 alkyl, C-Salkoxy, halogen, OH, CF , OCF, unsubstituted amino, C-alkoxycarbonyl; Au Independently represent a 6-membered heterocycle containing from 1 to 2 nitrogen atoms and possibly condensed with a benzene ring; or their pharmaceutically acceptable salts or complex alkyl esters in the form of individual optical isomers, or mixtures thereof. In this case, the effective dose, as a rule, is 0.005-1.5 mg / kg of body weight at least once a day. |
| priorityDate | 2010-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 154.